ADOCIA loses exclusive rights to negotiate M1P partnership

ADOCIA announces the expiration of its exclusive rights to negotiate a partnership for M1P.

Published 5sem1 sourceupdated 3j

≈ 18sSpeed

The fact

The project focused on an innovative diabetes treatment, with no final agreement.

The company is now exploring alternative strategic options for 2026.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on July 3, 2026